Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
|
9366572 |
1997 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Hereditary haemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome) is an autosomal dominant disorder characterized by localized angiodysplasia due to mutations in endoglin, ALK-1 gene, and a still unidentified locus.
|
16429404 |
2006 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?
|
8728706 |
1996 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
|
30763665 |
2019 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1.
|
10702408 |
2000 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This is the first experimental demonstration that a 5'-UTR mutation can prevent translation of ENG among HHT patients, and further supports the previous notion that haploinsufficiency is the primary mechanism of HHT1.
|
21967607 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Hereditary Hemorrhagic Telangiectasia (HHT) patients with haploinsufficiency of endoglin (ENG, HHT1) or activin receptor-like kinase 1 (ALK1, HHT2) have a higher incidence of bAVM than the general population.
|
22571958 |
2012 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Endoglin and ALK1 mutations are thought to affect endothelial cell metabolism, angiogenesis and vascular remodelling, even if the precise mechanism leading to the HHT lesions is still obscure.
|
18220803 |
2007 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia.
|
15521985 |
2004 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
|
30108051 |
2018 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.
|
29243366 |
2018 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
|
31630786 |
2019 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Familial cases have long been recognised and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, two other members of the transforming growth factor-β superfamily, activin-like kinase-type 1 (ALK1), and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia.
|
23733703 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.
|
15517393 |
2005 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
|
10545596 |
1999 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in endoglin result in the vascular defect known as hereditary hemorrhagic telangiectasia (HHT1).
|
21737454 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect.
|
10982033 |
2000 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
|
7894484 |
1994 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Thus, our study supports that screening for large rearrangements should be considered to improve the genetic analysis in HHT patients with no apparent mutations in ALK1 and ENG using direct sequencing.
|
18312453 |
2008 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Background Hereditary hemorrhagic telangiectasia ( HHT ) is a rare genetic vascular disorder caused by mutations in endoglin ( ENG ), activin receptor-like kinase 1 ( ACVRL 1; ALK 1), or SMAD 4.
|
30571376 |
2018 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
A novel ENG mutation causing impaired co-translational processing of endoglin associated with hereditary hemorrhagic telangiectasia.
|
22385575 |
2012 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.
|
15375013 |
2004 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
|
28796572 |
2017 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Linkage studies established an ORW locus at chromosome 9q3; endoglin was subsequently identified as the ORW1 gene.
|
8640225 |
1996 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in endoglin (ENG) or activin A receptor type II-like 1 (ACVRL1) account for around 90% of HHT patients, 10% of those are large deletions or duplications.
|
20412114 |
2010 |